Mazdutide 9mg results in mean percent change in body weight of 15.4% at 24 weeks
Innovent Biologics has revealed its phase 2 clinical study of higher dose (9mg) mazdutide in Chinese adults with obesity achieved the...
top of page
Browse by category
Search
Innovent starts Phase 2 Clinical Trial of mazdutide in Chinese adults with obesity
Innovent Biologics has announced that the first participant has been successfully dosed in the higher-dose cohort of a phase 2 clinical...
High-dose mazdutide may offer bariatric surgery-equivalent weight loss
Innovent Biologics has announced that the outcomes of high-dose cohorts in a phase 1 clinical trial of mazdutide (IBI362) - a...
Browse by tag
bottom of page